Phage Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
Phage Therapeutics will combat bacterial infections with bacteriophage, a well-known class of viruses that infect bacteria and destroy them. PhageTx has been collecting genetically diverse bacteriophage specific for Staphylococcus aureus and S. epidermidis--the company's initial targets for therapy.